2005-2011 年美国国际旅行相关弯曲杆菌感染的流行病学和抗菌药物耐药性。
Epidemiology and antimicrobial resistance of international travel-associated Campylobacter infections in the United States, 2005-2011.
机构信息
Emily E. Ricotta, Amanda Palmer, Patricia Ryan, and David Blythe are with the Maryland Department of Health and Mental Hygiene, Baltimore. Katie Wymore is with Public Health Foundation Enterprises, Oakland, CA. Paula Clogher is with the Yale School of Public Health, New Haven, CT. Nadine Oosmanally is with the Georgia Department of Public Health, Atlanta. Trisha Robinson is with the Minnesota Department of Health, St. Paul. Sarah Lathrop is with the University of New Mexico, Alburquerque. Jillian Karr is with the New York State Department of Health, Rochester. Julie Hatch is with the Oregon Health Authority, Public Health Division, Portland. John Dunn is with the Tennessee Department of Health, Nashville.
出版信息
Am J Public Health. 2014 Jul;104(7):e108-14. doi: 10.2105/AJPH.2013.301867. Epub 2014 May 15.
OBJECTIVES
The objective of this study was to determine the role international travel plays in US Campylobacter epidemiology and antimicrobial resistance.
METHODS
In this study, epidemiological and antimicrobial resistance data, encompassing the years 2005 to 2011, from 10 sites participating in the Foodborne Diseases Active Surveillance Network were linked. The 10 sites are represented by 7 states that conducted surveillance on a statewide level, and 3 states which conducted county-level surveillance. Cases of Campylobacter among persons with history of international travel in the week prior to illness were compared with cases among individuals with no international travel.
RESULTS
Approximately 18% of Campylobacter infections were estimated to be associated with international travel, and 60% of international travel-associated infections had a quinolone-resistant Campylobacter isolate.
CONCLUSIONS
We confirm that international travel plays a significant role in campylobacteriosis diagnosed in the United States. Recognizing this is important to both medical management decisions and understanding burden and attribution estimates of US campylobacteriosis and antibiotic-resistant campylobacteriosis.
目的
本研究旨在确定国际旅行在美国弯曲杆菌病流行病学和抗生素耐药性中所扮演的角色。
方法
在这项研究中，对参与食源性疾病主动监测网络的 10 个地点在 2005 年至 2011 年期间的流行病学和抗生素耐药性数据进行了关联。这 10 个地点代表了 7 个在全州范围内进行监测的州和 3 个进行县级监测的州。在发病前一周有国际旅行史的人群中，弯曲杆菌病例与没有国际旅行史的人群中的病例进行了比较。
结果
据估计，约 18%的弯曲杆菌感染与国际旅行有关，60%的国际旅行相关感染中存在对氟喹诺酮类药物耐药的弯曲杆菌分离株。
结论
我们证实，国际旅行在美国诊断出的弯曲杆菌病中起着重要作用。认识到这一点，对于医疗管理决策以及了解美国弯曲杆菌病和抗生素耐药性弯曲杆菌病的负担和归因估计都很重要。
Zotero 插件